Generative AI in China and the EU: What Businesses Need to Know
Globally, the accelerating spread of AI shows no sign of abating, and laws and regulations are under greater pressure to keep up. Wenpei Yu and Yunsi Hu of Lifeng Partners, together with Dr. Anja Geller of Redeker Sellner Dahs, provide an overview of the similarities and differences between the approaches taken in the EU and China, and what the future may hold.
Latest News
More News
In the News: Reverse CFIUS Scrutiny of Benchmark’s Chinese Investment; China M&A Recovery; and Delisting Threat of Chinese Companies
Legislation roundup: Antitrust, Trade secrets and Offering proceeds
Is the AIGC Platform an ‘Ultraman’ or a Normal Man? Artificial Intelligence and Copyright Infringement under Chinese Law
Comments on the New CAC Data Transfer Q&A
Features & Analyses
More Features & Analyses
Full Text Translations
More Full Text Translations
-
Q&A on Policies for Administration of the Security of Overseas Data Transfers
数据出境安全管理政策问答
CAC defines the necessity for overseas transfer of personal data
-
Measures for Labeling Synthetic Content Generated by Artificial Intelligence
人工智能生成合成内容标识办法
A service provider that provides online information content propagation services is required to verify AI labeling / CLP Reference: 5600/25.03.07 ; Promulgated: 2025-03-07 ; Effective: 2025-09-01
-
Guidelines for Compliance Audits of Personal Information Protection
个人信息保护合规审计指引
A compliance audit is required when processing personal information of more than 10 million persons / CLP Reference: 5600/25.02.12 ; Promulgated: 2025-02-12; Effective: 2025-05-01
-
Measures for the Administration of Compliance Audits of Personal Information Protection
个人信息保护合规审计管理办法
A compliance audit is required when processing personal information of more than 10 million persons / CLP Reference: 5600/25.02.12 ; Promulgated: 2025-02-12; Effective: 2025-05-01
-
Official Reply on the Issue of the Effectiveness of the Agreements of Hong Kong and Macao-Invested Enterprises Registered and Established in the Guangdong–Hong Kong–Macao Greater Bay Area in Which the Laws of Hong Kong or Macao are Selected as the Laws Governing the Contract or that Specify Hong Kong or Macao as the Seat of Arbitration
关于在粤港澳大湾区内地登记设立的香港、澳门投资企业协议选择港澳法律为合同适用法律或者协议约定港澳为仲裁地效力问题的批复
SPC clarifies on the contract governing law in Hong Kong and Macao investments in the Greater Bay Area / CLP Reference: 1450/25.02.13 ; Promulgated: 2025-02-13 ; Effective: 2025-02-14
Law Digests
More Law Digests
-
Secretariat of the National Technical Committee 260 on Cybersecurity of Standardization Administration of China, Guidelines for Cybersecurity Standards Practices—Requirements for Compliance Audits of Personal Information Protection (Draft for Comments)
全国网络安全标准化技术委员会秘书处网络安全标准实践指南——个人信息保护合规审计要求 (征求意见稿)
Standards are released specifying compliance audits of personal information protection / Issued: 2025-04-24
-
China Securities Regulatory Commission, Provisions for the Administration of the Deferment and Exemption of Listed Company Information Disclosures
中国证券监督管理委员会上市公司信息披露暂缓与豁免管理规定
CSRC exempts state secrets from company disclosure / CLP Reference: 2300/25.04.07 ; Promulgated: 2025-04-07 ; Effective: 2025-07-01
-
Guangzhou Development District (Huangpu District), Implementing Rules for Direct Equity Investment by Science and Technology Innovation and Venture Capital Funds of Funds
广州开发区 (黄埔区) 科技创新创业投资母基金直接股权投资实施细则
Guangzhou allows 100% loss in a seed direct investment or angel direct investment / CLP Reference: 3700/25.02.10/GZ ; Issued: 2025-02-10 ; Effective: 2025-02-10 (for three years)
-
Ministry of Justice, Measures for the Administration of Anti-Money Laundering Work in the Law Profession (Draft for Comments)
司法部律师行业反洗钱工作管理办法 (征求意见稿)
Law firms are required to establish a client due diligence system for anti-money laundering purposes / Issued: 2025-04-10
-
General Administration Department of the National Medical Products Administration, Working Procedures for the Protection of Pharmaceutical Trial Data (Draft for Comments)
国家药监局综合司药品试验数据保护工作程序 (征求意见稿)
NMPA details procedures for applying for pharma data protection / Issued: 2025-03-19